|
IVD Market Reaches $69.2 Billion: Kalorama Information Report
Friday, August 30, 2019
ARLINGTON, Va., Aug. 30, 2019 /PRNewswire/ -- The world market for diagnostics is estimated at $69.2 billion in 2019 and is expected to grow a little more than 4% annually to reach $85.2 billion by 2024. This is according to a new report by market researcher Kalorama Information, part of Science and Medicine Group. This includes all laboratory and hospital-based in vitro diagnostic (IVD) tests, instruments, and reagents, as well as over-the-counter (OTC) product sales.
Kalorama Information released its 12th edition of the 2,000-page "Worldwide Market for In Vitro Diagnostic Tests" report, available now: https://kaloramainformation.com/product/the-world-market-for-in-vitro-diagnostic-tests-12th-edition/.
Some of the key the findings of the report include the following:
-- The demand for early detection of cancer and infectious diseases is
driving the IVD market globally.
-- The market is also boosted by the aging world population and the stream
of new test innovations - this is a field where double-digit percentages
of sales invested back in R&D is not uncommon.
-- Sales to China, Korea, Brazil, and other emerging nations are driving
markets, but there is also some recovery in European markets and in
Japan.
-- Mass spectrometry has arrived, the report said, and it is included in
market totals for its superior microorganism identification capability,
among other applications.
-- Roche dominates the market, but Abbott Diagnostics has gained ground
recently. Siemens Healthcare, Danaher, Thermo Fisher Scientific,
bioMérieux, and Ortho Clinical Diagnostics are among the top-tier
competitors.
-- Hundreds of companies compete in the market, and investment is brisk.
The report covers every aspect of in vitro diagnostic testing from point-of-care tests to molecular genetic testing to tissue-based tests. Companies are profiled, trends tracked, and their impact discussed. Kalorama now publishes the comprehensive report yearly, and the firm is consulted by top diagnostic companies for business planning.
About Kalorama Information
For more than 30 years, Kalorama Information has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), imaging, biotechnology, healthcare, medical devices, and pharmaceuticals.
View original content to download multimedia:http://www.prnewswire.com/news-releases/ivd-market-reaches-69-2-billion-kalorama-information-report-300909768.html
SOURCE Kalorama Information
|
|
|
|
|
|
 |
PayDo Launches Unified Payment Infrastructure Suite for Digital Businesses | Jan 22, 2026
|
|
The New Identity Theft Crisis: AI Scams, Child Victims, and Credit Damage Are All Spiking | Jan 22, 2026
|
|
Fintech Startup BON Credit Secures $3.5 Million In Funding | Jan 22, 2026
|
|
AllSci Launches Hypothesis Publishing: A Seamless Way to Share, Connect, and Advance Scientific Ideas | Jan 22, 2026
|
|
Darwin CX Caps a Banner Year with AI Launch, Sold-Out Events, and Industry Book Launch | Jan 22, 2026
|
|
Gametime Launches "12 Days of Gametime" Holiday Giveaway in Partnership with Barstool Sports | Jan 22, 2026
|
|
Canadian Fintech Tuhk Inc., Founded by Ethoca and NuData Security Veterans, Raises US$6 Million Seed Round Led by FINTOP, with Lloyds Banking Group and Capital One Ventures | Jan 22, 2026
|
|
TSX Venture Exchange Market Data Now Available Across Over 40 Blockchains via Chainlink | Jan 22, 2026
|
|
Nudge Security Unveils Industry's Most Comprehensive AI Security Governance Platform | Jan 22, 2026
|
|
Young Adult Sports Fiction Debut Featured in LibraryBub Selection for January | Jan 22, 2026
|
|
|
|
